Relationship between Kinetic Properties of Mutant Enzyme and Biochemical and Clinical Responsiveness to Biotin in Holocarboxylase Synthetase Deficiency
Open Access
- 1 December 1999
- journal article
- Published by Springer Nature in Pediatric Research
- Vol. 46 (6) , 671
Abstract
Holocarboxylase synthetase (HCS) deficiency is a metabolic disorder that causes a biotin-responsive multiple carboxylase deficiency. We analyzed the kinetic properties of seven mutant HCS proteins. Two of these enzymes harbored mutations within the putative biotin-binding region of HCS and showed elevated Km values for biotin compared with that of the wild-type form (Km mutant; Gly581Ser: 45 times, delThr610: 3 times). The remaining five mutations (Arg183Pro, Leu216Arg, Leu237Pro, Val333Glu, and Val363Asp) were located outside the biotin-binding region. The enzymes containing these mutations showed normal or low Km values for biotin (non-Km mutant). Symptoms of patients who have the non-Km mutants, as well as those of patients who have the Km mutants, responded to biotin therapy. This is probably because the Km value for biotin of normal HCS is higher than the physiologic concentration of biotin in human cells. The Vmax values of all mutant HCS proteins were considerably decreased, but to a variable degree. The responsiveness to biotin supplementation of propionyl-CoA carboxylase activity in cultured cells bearing the mutations correlated well with the degree of reduction in the Vmax of HCS. Patients who have mutant HCS proteins with lower Vmax showed poorer clinical and biochemical responses to biotin therapy. These observations suggest that the reduction of Vmax is an essential factor for pathophysiology and prognosis of HCS deficiency under treatment with large amounts of biotin. The determination of HCS genotype can be valuable for characterizing the clinical phenotype in HCS deficient patients.Keywords
This publication has 20 references indexed in Scilit:
- Holocarboxylase synthetase deficiency: Report of a case with onset in late infancyJournal of Inherited Metabolic Disease, 1999
- Late-onset holocarboxylase synthetase-deficiency: pre- and post-natal diagnosis and evaluation of effectiveness of antenatal biotin therapyEuropean Journal of Pediatrics, 1998
- Characterization of Mutant Holocarboxylase Synthetase (HCS): AKm for Biotin Was Not Elevated in a Patient with HCS DeficiencyPediatric Research, 1997
- Five Patients with a Biotin-Responsive Defect in Holocarboxylase Formation: Evaluation of Responsiveness to Biotin Therapy in Vivo and Comparative Biochemical Studies in Vi1Pediatric Research, 1997
- Enzymatic diagnosis of holocarboxylase synthetase deficiency using apo-carboxyl carrier protein as a substrateClinica Chimica Acta, 1996
- Late‐onset holocarboxylase synthetase deficiencyJournal of Inherited Metabolic Disease, 1996
- Isolation of a cDNA encoding human holocarboxylase synthetase by functional complementation of a biotin auxotroph of Escherichia coli.Proceedings of the National Academy of Sciences, 1995
- Isolation and characterization of mutations in the human holocarboxylase synthetase cDNANature Genetics, 1994
- Holocarboxylase synthetase deficiency: Early diagnosis and management of a new caseEuropean Journal of Pediatrics, 1993
- Clinical and biochemical findings on a child with multiple biotin‐responsive carboxylase deficienciesJournal of Inherited Metabolic Disease, 1982